Colorectal Cancer Drugs Market Trends Include Mergers And Acquisitions

Colorectal Cancer Drugs Market Report 2021: COVID-19 Impact And Recovery To 2030

Colorectal Cancer Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030

The Business Research Company’s Colorectal Cancer Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030

LONDON, GREATER LONDON, UK, March 24, 2021 /EINPresswire.com/ — Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports

In April 2019, Bristol-Myers Squibb Company, an American pharmaceutical company, got the approval to acquire Celgene Corporation for $74 billion. Celgene Corporation is a company that develops medicines for cancer and inflammatory disorders. The transaction is expected to create a leading specialty company which would address the needs of patients with cancer, inflammatory and immunologic disease and cardiovascular disease through high-value innovative medicines and leading scientific capabilities. Such mergers and acquisitions are important trends in the colorectal cancer drugs market.

The colorectal cancer drugs market consists of sale of colorectal cancer drugs. Colorectal cancer (CRC) or bowel cancer, is the cancer affecting the large intestine and the rectum. It is also named colon tumor or rectal cancer depending upon where it begins.

Read More On The Global Colorectal Cancer Drugs Market Report:
https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report

The market covered in the colorectal cancer drugs market report is segmented by type into vascular endothelial growth factor (VEGF) inhibitors, epidermal growth factor receptor (EGFR) inhibitors, programmed cell death protein 1/pd1 ligand 1 (PD1/PDL1) inhibitors, BRAF or MEK inhibitors, tyrosine kinase (TKI) inhibitors, immunomodulators, by distribution channels into hospitals pharmacies, retail pharmacies, others, and by class into immunotherapy, chemotherapy, others.

The global colorectal cancer drugs market size is expected to decline from $6.23 billion in 2020 to $6.09 billion in 2021 at a compound annual growth rate (CAGR) of -2.2%. The slow decline is mainly due to the outbreak of COVID-19 that has led to decrease in demand for immunocompromised treatments. The colorectal cancer market is expected to reach $6.85 billion in 2025 at a CAGR of 3%.

Major players in the colorectal cancer drugs industry are Merck & Co. Inc., Roche, Sanofi, Amgen, and Pfizer, Inc.

Colorectal Cancer Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030 is one of a series of new reports from The Business Research Company that provides colorectal cancer drugs market overview, forecast colorectal cancer drugs market size and growth for the whole market, colorectal cancer drugs market segments, and geographies, colorectal cancer drugs market trends, colorectal cancer drugs market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Colorectal Cancer Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2590&type=smp

Here Is A List Of Similar Reports By The Business Research Company:
Oncology Drugs Market – By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Interventional Oncology Devices Global Market Report 2021: COVID 19 Growth And Change to 2030
https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report-2020-30-covid-19-growth-and-change

CAR-T Therapy Market – By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/car-t-therapy-market

Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology. TBRC excels in company, market, and consumer research.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn

Related posts